These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6331672)

  • 21. Impact of dialysis duration and glucose absorption on nutritional indices in stable continuous ambulatory peritoneal dialysis patients.
    Pajek J; Gucek A; Kveder R; Bucar-Pajek M; Kaplan-Pavlovcic S; Bren AF
    J Ren Nutr; 2008 Nov; 18(6):503-8. PubMed ID: 18940653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
    Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The outcome of peritonitis in patients on automated peritoneal dialysis.
    Yishak A; Bernardini J; Fried L; Piraino B
    Adv Perit Dial; 2001; 17():205-8. PubMed ID: 11510277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of peritoneal dialysis modality and acidosis on nutritional status in peritoneal dialysis patients.
    Dumler F; Falla P; Butler R; Wagner C; Francisco K
    Adv Perit Dial; 1998; 14():205-8. PubMed ID: 10649725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal transplantation in patients on continuous ambulatory peritoneal dialysis.
    Gokal R; Ramos JM; Veitch P; Proud G; Taylor RM; Ward MK; Wilkinson R; Kerr DN
    Proc Eur Dial Transplant Assoc; 1981; 18():222-7. PubMed ID: 7036149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infection rates in end-stage renal disease patients treated with CCPD and CAPD using the UltraBag system.
    Ghahramani N; Gorban-Brennan N; Kliger AS; Finkelstein FO
    Adv Perit Dial; 1995; 11():164-7. PubMed ID: 8534695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transport of peritoneal membrane assessed before and after the start of peritoneal dialysis.
    La Milia V; Limardo M; Cavalli A; Crepaldi M; Locatelli F
    Nephrol Dial Transplant; 2009 Sep; 24(9):2894-8. PubMed ID: 19349295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal changes of peritoneal function calculated by personal dialysis capacity in a patient after long-term continuous ambulatory peritoneal dialysis.
    Nakamoto H; Takane H; Sugahara S; Kanno Y; Okada H; Yamamoto T; Suzuki H
    Adv Perit Dial; 2003; 19():97-102. PubMed ID: 14763042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of continuous ambulatory peritoneal dialysis (CAPD) in patients of chronic renal failure.
    Banerjee S; Ratnu KS
    J Assoc Physicians India; 1984 Jun; 32(6):495-8. PubMed ID: 6511726
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmacokinetics of phenytoin in continuous ambulatory peritoneal dialysis. 2 cases and brief review of the literature].
    Hess B; Keusch G; Flückiger J; Binswanger U
    Schweiz Med Wochenschr; 1984 Jan; 114(1):16-9. PubMed ID: 6695161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicentre study of physical activity and employment status of continuous ambulatory peritoneal dialysis (CAPD) patients in the United States.
    Fragola JA; Grube S; Von Bloch L; Bourke E
    Proc Eur Dial Transplant Assoc; 1983; 20():243-9. PubMed ID: 6657661
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of increasing exchange volume and frequency on peritoneal dialysis adequacy.
    Gao H; Lew SQ; Bosch JP
    Clin Nephrol; 1998 Dec; 50(6):375-80. PubMed ID: 9877111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dialysis adequacy indices in high membrane transporters treated with short-dwell peritoneal dialysis.
    Strauss FG; Holmes DL; Dennis RL
    Adv Perit Dial; 1995; 11():110-3. PubMed ID: 8534681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary experience with continuous ambulatory peritoneal dialysis.
    Rahman M; Haq SA; Haq A
    Bangladesh Med Res Counc Bull; 1982 Dec; 8(2):52-8. PubMed ID: 7184498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experiences with continuous ambulatory peritoneal dialysis (CAPD) at the University Clinic for Internal Medicine in Innsbruck].
    König P; Spielberger M; Vogel W; Dittrich P
    Wien Klin Wochenschr; 1983 Mar; 95(5):168-71. PubMed ID: 6858173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diphtheroid peritonitis associated with continuous ambulatory peritoneal dialysis.
    Leung AC; Orange G; Henderson IS; Kennedy AC
    Clin Nephrol; 1984 Oct; 22(4):200-5. PubMed ID: 6509806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sleep disorders in patients treated with continuous ambulatory peritoneal dialysis].
    Kalousová M; Tesar V; Sonka K; Sulková S; Znojová M; Jelínková E; Merta M; Bodláková B
    Sb Lek; 2001; 102(3):395-400. PubMed ID: 12092125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal comparison of intermittent versus continuous ambulatory peritoneal dialysis, in the same patients.
    Madden MA; Zimmerman SW; Simpson DP
    Clin Nephrol; 1981 Dec; 16(6):293-9. PubMed ID: 6797767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Peritoneal blood flow, peritoneal transfer and continuous ambulatory peritoneal dialysis].
    Grzegorzewska A; Sliwowski A
    Pol Merkur Lekarski; 1997 Sep; 3(15):122-5. PubMed ID: 9461708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.